Plant ID: NPO14197
Plant Latin Name: Patrinia Scabra
Taxonomy Genus: Patrinia
Taxonomy Family: Caprifoliaceae
NCBI TaxonomyDB:
180074
Plant-of-the-World-Online:
n.a.
China
Ingredient ID: NPC98711
Ingredient ID: NPC8965
Ingredient ID: NPC88983
Ingredient ID: NPC83893
Ingredient ID: NPC83108
Ingredient ID: NPC75844
Ingredient ID: NPC71152
Ingredient ID: NPC65665
Ingredient ID: NPC52576
Ingredient ID: NPC478850
Ingredient ID: NPC478849
Ingredient ID: NPC478848
Ingredient ID: NPC478847
Ingredient ID: NPC478846
Ingredient ID: NPC478845
Ingredient ID: NPC478844
Ingredient ID: NPC470660
Ingredient ID: NPC470659
Ingredient ID: NPC470658
Ingredient ID: NPC470657
Ingredient ID: NPC37866
Ingredient ID: NPC31349
Ingredient ID: NPC307699
Ingredient ID: NPC298093
Ingredient ID: NPC279575
Ingredient ID: NPC259685
Ingredient ID: NPC249408
Ingredient ID: NPC248793
Ingredient ID: NPC246173
Ingredient ID: NPC235051
Ingredient ID: NPC231710
Ingredient ID: NPC216826
Ingredient ID: NPC180301
Ingredient ID: NPC179970
Ingredient ID: NPC152477
Ingredient ID: NPC120021
Ingredient ID: NPC116970
Ingredient ID: NPC106814
Ingredient ID: NPC104129
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Therapeutic Target | Oxidoreductase | ND4 | NADH-ubiquinone oxidoreductase chain 4 | P03905 | CHEMBL4499 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Phosphodiesterase | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Therapeutic Target | Protein Kinase | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Therapeutic Target | Small molecule receptor (family A GPCR) | HTR6 | Serotonin 6 (5-HT6) receptor | P50406 | CHEMBL3371 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Unclassified protein | PMP22 | Peripheral myelin protein 22 | Q01453 | CHEMBL1293298 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 1215 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00045747 | UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00021398 | Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | cutaneous melanoma;Fallopian Tube Carcinoma;metastatic melanoma;renal cell carcinoma;non-small cell lung carcinoma;ovarian carcinoma;breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003777 | Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02494973 | Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003446 | Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01326000 | A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00066846 | Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00813137 | FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01526135 | Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03800693 | 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT01621217 | Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 | anal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03722498 | Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002883 | Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00020917 | Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00571740 | Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01127555 | Salvage mFOLFOX in BTC After Failure of Gemcitabine | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT04488159 | Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00449137 | Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03503604 | A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03428529 | Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02375672 | Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00052429 | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01181401 | InductionChemo-Radio-Antibody-Treatment | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03127007 | Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01154920 | Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01338558 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01442935 | Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01494363 | Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT03861702 | Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04354662 | Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05466799 | FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00370760 | Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) | proliferative vitreoretinopathy | Fluorouracil (NPC75844) | NP level |
NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00807911 | Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01312350 | Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03607656 | The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02270606 | Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01591733 | FOLFIRINOX + RT for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04808323 | MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03192618 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00429299 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01204437 | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00507091 | Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02178709 | A Phase II Study of Neoadjuvant FOLFIRINOX | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02578368 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02246127 | Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced Pancreatic Neuroendocrine Tumor (pNET) | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05268510 | Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02777437 | Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03161574 | FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00525759 | Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00020787 | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03342352 | Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00413322 | Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00544362 | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00006037 | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00066274 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03771846 | HAIC Versus Systemic Chemotherapy for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Fluorouracil (NPC75844) | NP level |
NCT01611857 | Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02648425 | Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02225652 | A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01524094 | Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00055679 | Combination Chemotherapy in Treating Women With Stage I Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01197664 | Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00955240 | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04151277 | PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03002064 | Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01622543 | Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01985841 | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT05132504 | Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04068103 | Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03110926 | Induction Chemotherapy for Locally Advanced Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05171166 | Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00090025 | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT02296671 | Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00008060 | Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03487939 | Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02720068 | Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05166772 | Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)in the First-line Treatment of Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01862003 | Phase I/II Trial of Antagonism of HER in GI Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03675737 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003637 | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002896 | Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00046995 | Combination Chemotherapy in Treating Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00981656 | Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01205022 | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00023868 | Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00182715 | Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00497497 | A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01277406 | 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00016198 | Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01013805 | Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00378716 | Combination Chemotherapy in Treating Patients With Resected Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00199797 | Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03291899 | Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01142414 | Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01542931 | TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02887313 | FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01836653 | Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01633970 | A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT05125055 | Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05065801 | Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03152370 | Preoperative Radiotherapy and E7046 in Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04120701 | CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01937507 | Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03082209 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT03336216 | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02921256 | Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03340896 | Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00381706 | Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00006248 | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003576 | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00024349 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT03693677 | First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04031703 | Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00615056 | A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00551213 | A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004094 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02141295 | A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00075595 | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00500292 | A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT03069950 | Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02047201 | Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02942563 | Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03883919 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01068132 | Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00861094 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00640081 | Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02485548 | Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02506842 | Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00053911 | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00423293 | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT01220128 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04371224 | NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003627 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01126216 | Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00954512 | Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03468231 | HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03484195 | Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01121848 | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05201430 | Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00423696 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01333709 | Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003799 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01171482 | Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01374425 | Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01628211 | Second Look Laparoscopy in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01454180 | Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05083247 | Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00385021 | ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00261703 | Docetaxel in Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03167164 | QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
NCT03883802 | Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03837977 | Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00087178 | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05217069 | A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00006786 | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05209074 | Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002783 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01417494 | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04390399 | Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00448136 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01133990 | FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02291289 | A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01086826 | Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03197571 | QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | urothelial carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04752696 | Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03484299 | Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00217737 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | Lynch syndrome;signet ring cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002579 | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02383966 | Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02830139 | Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00003994 | Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT01269229 | A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02218164 | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma | skin carcinoma;squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02351219 | FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03443492 | SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02959879 | Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004257 | Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02413853 | Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01608464 | Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387111 | QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00201396 | A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01821729 | Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01911598 | A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002884 | Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04005339 | NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01314833 | Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02400567 | Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02941562 | A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002692 | Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04672005 | Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05047991 | Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02465593 | A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03586869 | QUILT-3.080: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03085992 | Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01473303 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00665392 | Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02845908 | POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04994236 | Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01704703 | Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04757363 | A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00303628 | Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04961970 | HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01376453 | Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00577109 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002828 | Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00098982 | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01383343 | Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03387098 | QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02426450 | RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02128100 | Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03869034 | HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00262951 | Chemoradiation in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00335816 | Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00941655 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00005979 | Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00124111 | A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04428333 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | head and neck neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05412082 | SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01270373 | NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02369939 | Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | anal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00077233 | FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00719797 | Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05229497 | FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC | cancer | Fluorouracil (NPC75844) | NP level |
NCT03563144 | QUILT-3.088: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01046864 | Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) | cancer | Fluorouracil (NPC75844) | NP level |
NCT00265811 | Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03548961 | Organ Preservation in Early Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01905150 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00089024 | Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00747799 | Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003063 | Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00417209 | Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04495088 | Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00193882 | Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03421353 | AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00460265 | Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003012 | Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04480190 | Neoadjuvant Therapy in Biliary Adenocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00289445 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | metastasis;neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003888 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03329248 | QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00101894 | Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03748134 | Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00471484 | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT02008656 | Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04155671 | POF Versus FOLFOX Plus IP Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00303771 | Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00720512 | Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02897050 | Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04356170 | Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02132949 | A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02019355 | Actinic Keratosis Study | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02704520 | Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03279237 | A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00006051 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04004871 | Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | laryngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02676349 | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00143403 | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | colorectal neoplasm;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01500993 | Capecitabine in the Perioperative Treatment of Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02885753 | Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02340949 | Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02172976 | Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00021281 | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00096278 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002581 | Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04418895 | Neoadjuvant Therapy for Localized Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03603834 | Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01896531 | A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02028806 | mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00268398 | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02591030 | Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours | bile duct cancer | Fluorouracil (NPC75844) | NP level |
NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03300609 | 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002897 | Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01099358 | Study in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00268333 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02934464 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03224221 | Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01150045 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01748851 | XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03991962 | Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02402842 | Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma | anal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01765582 | Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05314998 | Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003118 | Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00941499 | Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | cancer | Fluorouracil (NPC75844) | NP level |
NCT02681003 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00526110 | Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01238965 | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01177956 | A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03778593 | FOLFIRINOX for 2nd-line Treatment of BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT05476432 | HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03081143 | Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02973685 | HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002593 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02021422 | A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00736944 | Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003862 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02897700 | A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02590367 | Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | peripheral neuropathy | Fluorouracil (NPC75844) | NP level |
NCT04084496 | mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03888677 | Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002999 | S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00000758 | A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women | dysplasia of cervix | Fluorouracil (NPC75844) | NP level |
NCT01347645 | Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00112918 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003086 | Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01283204 | Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02217020 | Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00033735 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02450058 | Adjuvant FEC Versus EP in Breast Cancer (MIG5) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02641691 | Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02827201 | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03921684 | Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01354717 | Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00042874 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02459457 | A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04185883 | Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00049101 | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00309569 | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05033522 | Immunotherapy for Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02588105 | Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01248299 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00052559 | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05251038 | Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01494506 | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05029973 | HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00677118 | Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002870 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02580253 | Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03504423 | Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00129922 | Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03043729 | mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00721513 | Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02981498 | Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03600623 | Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00705016 | Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00416507 | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03668730 | Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT00868491 | Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00943137 | The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT03781323 | Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | basal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03641976 | A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00160030 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00608205 | Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00544414 | Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05253846 | Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04217954 | HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT02246049 | A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01802645 | Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00220649 | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00047099 | Combination Chemotherapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01198392 | Trial of S-1 Plus Cisplatin in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04821284 | Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02124148 | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00049348 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02041481 | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003018 | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00865189 | A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04749108 | Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04919226 | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00755118 | Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03189719 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590) | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01774786 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01930552 | A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01442649 | Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01489865 | ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00416858 | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03169790 | QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT00246103 | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00537823 | Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04009876 | A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05239741 | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03358472 | Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02742051 | A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01536223 | Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00193141 | Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002551 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04807972 | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04170530 | Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00501410 | FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05081687 | Brazilian Total Neoadjuvant Therapy Trial | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00215514 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00838370 | Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02358031 | A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01418222 | FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00454116 | A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03487016 | First-line Therapy in Metastatic PDAC | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01953406 | The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02741570 | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03785873 | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00072553 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02551991 | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00202774 | Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04793932 | Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03736720 | Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin | pancreatic endocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04675983 | A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02514278 | Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03941093 | Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05214339 | A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00042861 | UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT00992199 | Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03386838 | An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05179889 | Adjuvant FOLFOXIRI for High-risk Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04324307 | Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04130854 | INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04380337 | Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03387592 | CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05024513 | Biliary Drainage Plus HAIC in Locally Advanced pCCA | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00402545 | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01888978 | Molecularly Tailored Therapy for Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01348217 | Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02167321 | Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00212589 | Patients Preference for Oral or i.v. Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00570531 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002542 | Tamoxifen in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04379596 | Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2+ Gastric Cancer (DESTINY-Gastric03) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00286000 | High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004150 | High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003172 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003893 | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04611724 | Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients | cancer | Fluorouracil (NPC75844) | NP level |
NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01270438 | Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01276379 | Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05319639 | Phase I Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01528618 | Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03050814 | Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00016952 | Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00831181 | Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02967887 | Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002839 | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04420884 | A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00352755 | A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis | peritoneal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00392704 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03368859 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | cancer | Fluorouracil (NPC75844) | NP level |
NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02059499 | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions | anal neoplasm;squamous cell intraepithelial neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01167725 | Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02423226 | Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002888 | Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00613080 | Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00498953 | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05078827 | Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT02482441 | A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | chronic myeloproliferative disorder;multiple myeloma;myelodysplastic syndrome | Fluorouracil (NPC75844) | NP level |
NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT05009069 | A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00091312 | Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00070122 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02268695 | Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00026364 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00849264 | Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | thrombotic disease;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00023751 | Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03020329 | Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00000122 | Fluorouracil Filtering Surgery Study (FFSS) | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT03671252 | Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04393584 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04523818 | Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | gastrointestinal stromal tumor;esophageal cancer;gastric cancer;pancreatic carcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003298 | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04839731 | Combination 5-FU / Calcipotriene Cream for SCCIS/SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04292743 | Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01632306 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00782041 | Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | uterine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03048123 | HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01804790 | Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002498 | Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03780049 | HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04423965 | A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01446458 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01946074 | A Study of ABT-165 in Subjects With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03169764 | QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03524508 | Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00268372 | S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05108428 | Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01652482 | Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03760614 | A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04481204 | New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04859582 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00193284 | Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00773695 | A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00055601 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT04229459 | Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00208936 | Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
NCT00811447 | Taxotere New Indication - Gastric Cancer Treatment Registration Trial | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00646659 | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00872625 | Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02774187 | Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05350943 | HAIC Combined With Toripalimab and Donafenib for Advanced BTC | biliary tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01332604 | GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT02534337 | Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02672917 | Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05052099 | Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00006366 | Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02688712 | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01787006 | Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03563248 | Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02969473 | Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma | neoplasm of esophagus | Fluorouracil (NPC75844) | NP level |
NCT03780634 | HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04469556 | Pancreatic Adenocarcinoma Signature Stratification for Treatment | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03197584 | QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT03042780 | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas | pancreatic endocrine carcinoma;pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00070213 | Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00427310 | Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03192644 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00427570 | Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03300544 | Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01750918 | Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01572324 | Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT01525329 | Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01302613 | Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00551759 | Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00611507 | A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02616601 | Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT01627379 | Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00999700 | Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01060007 | Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00081289 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00499850 | Phase I FOLFOX Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006115 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03732508 | SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00166465 | Stage IV Colorectal CA ALIMTA | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00632333 | Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03370406 | Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00468169 | Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00995293 | Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00149201 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT02515734 | A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02289768 | Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT02142322 | Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02795988 | A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04589234 | Saltikva for Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00316888 | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT04510064 | PD-1 Antibody Combined With Modified FLOT Regimen in the Treatment of Unresectable Locally Advanced or Limited Metastatic Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00112658 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01503372 | FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002735 | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00004206 | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT01522989 | PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00615602 | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03085914 | A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02820857 | Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00001498 | A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00121992 | Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02319018 | Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT00556413 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04722133 | Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03881111 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01362374 | Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03067792 | FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01413022 | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02405585 | Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04127019 | Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03563170 | QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00065117 | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT01498783 | Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma | central nervous system cancer;ependymoma | Fluorouracil (NPC75844) | NP level |
NCT04937738 | Perioperative Chemotherapy in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01216111 | Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00642577 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04478292 | A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT03803254 | HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01226719 | FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00647530 | Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00058474 | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04241185 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | bladder tumor | Fluorouracil (NPC75844) | NP level |
NCT00005586 | Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT02625610 | Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04854499 | Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05348811 | HAIC Combined With Donafenib and Sintilimab for Unresectable ICC | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04437329 | Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05263219 | DEB-TACE+HAIC vs. HAIC for Large HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00274937 | Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02071069 | Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00324415 | Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02468557 | Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05235542 | A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00009737 | A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02842580 | De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004097 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01566435 | Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01472016 | Study of ABT-700 in Subjects With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04550260 | Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002793 | Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01479465 | Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003260 | Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00174707 | Study of Docetaxel in Breast Cancer Patients | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | peritoneum cancer | Fluorouracil (NPC75844) | NP level |
NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00873275 | Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04303429 | Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03939962 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00026130 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387085 | QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01383707 | A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00098787 | Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003596 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT04161755 | Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02967289 | IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03037541 | Cryosurgery and Cream Combination for Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT01889303 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00349076 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00611858 | Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05015621 | A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02244632 | Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02023593 | FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002696 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05074966 | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00952029 | Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00054054 | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03175666 | QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00940303 | OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03281369 | A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) | esophageal carcinoma;gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01206465 | Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01941641 | Colon Neoadjuvant FOLFOXIRI Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00062426 | Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002755 | Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00660270 | Chemotherapy and Radiation Following Pancreatic Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02025023 | Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study | meibomian cyst | Fluorouracil (NPC75844) | NP level |
NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01263171 | Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01605344 | Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00711243 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00976768 | Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00296608 | Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01047293 | RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01490866 | A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03168607 | Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03899636 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01279681 | Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004003 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00145769 | A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003543 | Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00059826 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) | hypopharyngeal carcinoma;laryngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03812783 | HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00001569 | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | peritoneal neoplasm;carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT04149015 | Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05111860 | Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00041262 | Combination Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00541112 | Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03577704 | The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02384850 | Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00379262 | Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003422 | Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00820547 | Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00113399 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00479583 | Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX | cancer | Fluorouracil (NPC75844) | NP level |
NCT02241551 | Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00308516 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT00002525 | Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02353260 | Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04393298 | A Study to Assess the Safety, Pharmacokinetics and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03825861 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04649476 | Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00321685 | Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02767375 | Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01893294 | Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03443661 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04164238 | Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04927780 | Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00967616 | Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01225523 | Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00083109 | Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer | renal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003664 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01217060 | Trimodality Management of T1b Esophageal Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004931 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002580 | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05446467 | Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00601627 | Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04259944 | Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04838496 | Induction Chemotherapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04089150 | MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03806309 | Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02846428 | To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00377273 | An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT01769508 | Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00630032 | Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05378919 | Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00323011 | FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02937116 | A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT03605706 | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02440958 | Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003873 | Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | esophageal carcinoma;stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03130790 | Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00393068 | Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04228601 | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00155883 | Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04215731 | Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03169738 | QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02359968 | PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02723955 | Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01688336 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00103103 | Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002615 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04949256 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04875026 | Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00797485 | Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00602602 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02452853 | HR Combined With FOLFOX4 for HCC With PVTT | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | esophageal carcinoma;stomach neoplasm;adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02486601 | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01661088 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02884128 | A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05257993 | Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00539617 | Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00696488 | Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00004099 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00719199 | Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00129389 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00525785 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01652976 | Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05332002 | A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT02735239 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT01836029 | Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00025090 | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02365805 | Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04769414 | Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00237900 | Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04094688 | Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01245959 | Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03783442 | A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01716949 | Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05193292 | Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02115152 | Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01289821 | First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03167177 | QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy | melanoma | Fluorouracil (NPC75844) | NP level |
NCT00006111 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT00117572 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) | laryngeal neoplasm;oral cavity cancer;paranasal sinus neoplasm;pharynx cancer | Fluorouracil (NPC75844) | NP level |
NCT03727061 | Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer | head and neck carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01434069 | Phase I Trial of Combination of FOLFIRI and SOM 230 | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00544011 | Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00839111 | Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04003792 | Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02017600 | A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00541125 | G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02114359 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01081041 | A Study in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01653470 | Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens | cancer | Fluorouracil (NPC75844) | NP level |
NCT00188266 | Study of Adjuvant Radiochemotherapy for Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01914900 | Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00023660 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04325425 | Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02640365 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT05135364 | HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006103 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05213312 | Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02393833 | IBCSG Trial 22-00 Serum Substudy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04834206 | Nedaplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006472 | Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00625898 | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02755311 | Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00002747 | Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00069953 | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00958737 | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00548548 | A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05062889 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03970252 | Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02319304 | Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01858025 | Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02456714 | Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02012062 | Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01031030 | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02715531 | A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01704690 | Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00499603 | Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04990037 | A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03013218 | A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT01855828 | Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01676259 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05358704 | Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01634555 | A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02508077 | FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03484221 | Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01827553 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00321828 | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01523457 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | urinary bladder carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002496 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00069121 | A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00352105 | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05035381 | PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00004059 | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00025337 | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03092895 | A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04997837 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05493332 | HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01036087 | Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00953394 | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00963729 | Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04460352 | Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02527772 | Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05472259 | A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00068692 | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | mucinous carcinoma;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00889343 | Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00436267 | Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05329766 | A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT04755543 | A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02539537 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01183663 | Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) | cancer | Fluorouracil (NPC75844) | NP level |
NCT00343239 | Docetaxel in Locally Advanced Gastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00008281 | Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
NCT02024607 | BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) | cancer | Fluorouracil (NPC75844) | NP level |
NCT03764553 | Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03250832 | Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04832776 | FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01590719 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01481545 | Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01465451 | Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00388700 | A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02115204 | 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03812770 | Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00533936 | Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT00710736 | A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT05462496 | Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04539808 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01966471 | A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05433597 | A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03326947 | Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00278694 | Oxaliplatin and 5-FU Based Preoperative Chemoradiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00193219 | Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05360732 | Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00080951 | Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03554109 | QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02717091 | Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00112697 | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003680 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01871571 | Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01836432 | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02016417 | Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01324141 | Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT04897854 | Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006468 | Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04176952 | PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01375816 | Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04431258 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03331640 | A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02767219 | The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT00079274 | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05221658 | A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03426904 | Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00357149 | Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03879109 | Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01231802 | Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01274962 | A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01985724 | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03109158 | NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03164382 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT03574649 | QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004913 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02817113 | Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003577 | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00671372 | A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02648711 | Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03110510 | FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04962958 | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01047007 | A Dose Escalation Study of MK1775 in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00778102 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00015886 | Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03391843 | Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03910634 | IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00832299 | Neo-Adjuvant FOLFOX for Rectal Carcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00425152 | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00988897 | Colorectal Cancer RECHALLENGE | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003078 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT01233843 | Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00210184 | Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00004089 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05022030 | First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00983541 | Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma | cancer | Fluorouracil (NPC75844) | NP level |
NCT01467115 | Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00478946 | A Study of Picoplatin in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00467142 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02980965 | Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04908566 | Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00270543 | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02551159 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00387387 | Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002689 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00776724 | Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05469061 | Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04165772 | Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03306121 | TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00188877 | Intensity Modulated Radiation Therapy for Head and Neck Cancer | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05024097 | A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1 Checkpoint Inhibitor) in Combination With Short Course Radiotherapy and Consolidation Chemotherapy for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003594 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04502641 | Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00463840 | Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02494583 | Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03136406 | QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02000050 | Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00123318 | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00628810 | Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01286766 | Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002631 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01327521 | Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01285557 | Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00433420 | Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00036868 | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00047112 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04926753 | Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00309478 | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02281682 | IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT01372202 | CHFR Methylation Status Esophageal Cancer Study | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00555672 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00384878 | Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00592501 | Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01779050 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | colorectal adenocarcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00424827 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002893 | Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03323463 | Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma | oropharynx squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003585 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02352337 | First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04594772 | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00054587 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00400179 | A Safety and Efficacy Study in Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT00002716 | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00513383 | Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04370418 | A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab | cancer | Fluorouracil (NPC75844) | NP level |
NCT00022178 | Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04541108 | Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03143153 | A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT00003652 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT01591135 | A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Malignant neoplasms of rectum, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92.Z |
NCT02641691,NCT04703101,NCT04749108,NCT01333709,NCT02000050,NCT01804790,NCT00068692,NCT00308516,NCT01383343
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
NOS2
NCT00595972,NCT02563054,NCT01285557,NCT00005060,NCT04354662,NCT01590719,NCT00711243,NCT01774786,NCT05319639,NCT00210184,NCT03015675,NCT01851941,NCT02114359,NCT01041404,NCT02442362,NCT00400179,NCT01503372,NCT01286766,NCT02486601,NCT00188266,NCT00514020,NCT02142322,NCT00992199,NCT04859582,NCT04757363,NCT03694522,NCT00002883,NCT02845908,NCT04149015,NCT04379596,NCT00002783,NCT03607656,NCT00052910,NCT00142350,NCT01183559,NCT00976768,NCT00384878,NCT02934464,NCT00215514,NCT00054873,NCT04358341,NCT01198392,NCT00202969,NCT00003862,NCT00447967,NCT00857246,NCT00313872,NCT00270543,NCT00020787,NCT00002615,NCT00003172,NCT03825861,NCT03130790,NCT00155883,NCT00374036,NCT01896531,NCT01216644,NCT02296671,NCT00941655,NCT00525785,NCT01769508,NCT01889303,NCT00343239,NCT01924819,NCT03067792,NCT04358354,NCT04155671,NCT01662869,NCT00003298,NCT00002722,NCT03606928,NCT00811447,NCT02578368,NCT00149201,NCT00004873,NCT00123318,NCT02574663,NCT04937738,NCT00004099,NCT00555672,NCT04393584,NCT03939962,NCT00103103,NCT04997837,NCT01283204,NCT03675737,NCT00004233,NCT00611507 |
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT00126256,NCT02124148,NCT00289445,NCT00065117,NCT00149201,NCT00374036,NCT02419495
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
LMNA,TDP1,THPO,PMP22,TSHR,NOS2,SMN1
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NCT00020787,NCT03279237,NCT01183559,NCT00086996,NCT00008047,NCT00416858,NCT00632333,NCT01217060,NCT00002631,NCT01843049,NCT00054873,NCT00004257,NCT00209716,NCT03110926,NCT01348217,NCT00539617,NCT00551759,NCT00258323,NCT00425425,NCT03764553,NCT00193882,NCT00160030,NCT00209690,NCT00735345,NCT00193141,NCT00733889,NCT00003118,NCT00075738,NCT00004233,NCT03189719,NCT00002984,NCT00759226,NCT00052910,NCT03281369,NCT02023593,NCT00230451,NCT00544362,NCT00006472,NCT00047112,NCT00570531,NCT03002064,NCT03910634,NCT00002883,NCT00393068,NCT00525915,NCT00381706,NCT02359968,NCT01998347,NCT03881111,NCT01372202,NCT01787006,NCT02574663,NCT00915850,NCT01608464,NCT01704690,NCT00021320,NCT00041262,NCT02735239,NCT00861094,NCT00002897,NCT00002884,NCT01611857,NCT00069953,NCT00004897,NCT00259402
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT04420884,NCT02648711,NCT02588105,NCT00044785,NCT00413322,NCT00005791,NCT00042861,NCT00261703,NCT01566435,NCT00004059,NCT00007878,NCT04151277,NCT01362374,NCT00005068,NCT00838370,NCT00080990,NCT00995293,NCT04176952,NCT00042874,NCT00289445,NCT01930552,NCT03577704,NCT00004913,NCT00004242,NCT01634555,NCT00502567,NCT01522989,NCT04541108,NCT03085914,NCT02817113,NCT00357149,NCT04047862,NCT00043121,NCT04393298,NCT02715531,NCT00020488,NCT02723955,NCT02884128,NCT01946074,NCT00021073,NCT00954512,NCT00610948,NCT02720068,NCT01206465,NCT03326947,NCT04185883,NCT02648425,NCT01472016,NCT00811993,NCT04607421,NCT00024141,NCT02482441,NCT03250832,NCT01099358,NCT00402545,NCT03503604,NCT00215501,NCT00448136,NCT01047007,NCT00246103,NCT03421353
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
MTOR
NCT00471484,NCT00238160,NCT00507585,NCT03164382,NCT03092895 |
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT00006111,NCT00003175,NCT00003642,NCT00981656,NCT00055601,NCT00024349
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
PMP22,NOS2
NCT00003994,NCT04478292,NCT00980460,NCT03017326 |
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
MTOR
NCT00268372,NCT00003627,NCT02358031,NCT00003637,NCT00004094,NCT00052429,NCT02997332,NCT00006248,NCT00460265,NCT01126216,NCT03358472,NCT00646659,NCT00004164,NCT00608205,NCT00006051,NCT00352105,NCT00004097,NCT00003576,NCT00002747,NCT00004865,NCT00392704,NCT00093665,NCT00468169,NCT00004901,NCT00002839,NCT00054054,NCT02353260,NCT01911598,NCT04428333,NCT00003777,NCT00002496,NCT00544414,NCT00002735,NCT04356170,NCT03342352,NCT00002999,NCT01081041,NCT00665392,NCT00203905,NCT03386838,NCT00193284,NCT00002476,NCT00003888,NCT00868491,NCT00095875,NCT00498953,NCT02741570,NCT01467115,NCT00004089,NCT03727061,NCT00721513,NCT00122460,NCT00002888,NCT01142414,NCT00113399,NCT00352118 |
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT02767375,NCT00921531,NCT05166772,NCT05135364,NCT01327521,NCT03192618,NCT03469479,NCT00471965,NCT00849264,NCT03192644,NCT03468231,NCT05263219,NCT02774187,NCT04994236,NCT01953406,NCT02973685,NCT03869034,NCT03780049,NCT01775501,NCT04962958,NCT02580253,NCT02452853,NCT02981498,NCT05033522,NCT02426450,NCT03722498,NCT02987699,NCT00143403,NCT03812783,NCT05493332,NCT03780634,NCT02527772,NCT05476432,NCT02967887,NCT00559455,NCT03563170,NCT03812770,NCT02069041,NCT05214339,NCT02755311,NCT03605706,NCT05171166,NCT01055743,NCT00619541,NCT03048123,NCT05029973,NCT02534337,NCT01171482,NCT03803254,NCT00933816
|
Malignant neoplasms of stomach, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.Z |
NCT00509964,NCT01748851,NCT00237900,NCT02048540,NCT03081143
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT01220128,NCT00429299,NCT00174707,NCT00121992,NCT01779050
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT01121848,NCT01413022,NCT05083247,NCT00417209,NCT00220649
|
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT03603834,NCT02456714,NCT05348811,NCT04480190,NCT05024513
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
NCT04755543,NCT01434069,NCT03800693,NCT02319018
|
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00003585,NCT00053807,NCT00003664,NCT00053820
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
NOS2,HTR6,TDP1,TSHR
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CYP2C19,LMNA,PMP22,NOS2
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
CYP2C19,HTR6,THPO,NOS2
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT05179889,NCT00309543,NCT01111604,NCT04259944,NCT03641976,NCT04488159,NCT03883802,NCT01270438,NCT04303429,NCT02138617,NCT00499369,NCT00337389,NCT02510118,NCT02967289,NCT05174169,NCT00101894,NCT01238965,NCT04120701,NCT00079274,NCT01383343,NCT01205022,NCT03426904,NCT04832776,NCT00025337,NCT01347645,NCT00003835,NCT02041481,NCT00942266,NCT05062889,NCT00309530,NCT00070122,NCT01198548,NCT00193219,NCT00003873,NCT00004931,NCT04003792,NCT00646607,NCT00235898
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT01591135,NCT02485548,NCT03224221,NCT05469061,NCT03370406,NCT02459457,NCT04550260,NCT00705016,NCT05125055,NCT03783442,NCT01542931,NCT01914900,NCT04839731,NCT04649476,NCT03748134,NCT05213312,NCT01248299,NCT01836029,NCT02325986,NCT04949256,NCT01225523,NCT01181401,NCT03387111,NCT01627379,NCT03732508,NCT04926753,NCT05221658,NCT01391572,NCT03109158,NCT02218164,NCT02383966,NCT04460352,NCT04229459,NCT02017600
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT03970252,NCT05132504,NCT02468557,NCT01526135,NCT04539808,NCT02440958,NCT04752696,NCT05314998,NCT03977233,NCT04821284,NCT00054873,NCT04990037,NCT05257993,NCT04292743,NCT05209074,NCT00307723,NCT01676259,NCT02243007,NCT02959879,NCT00548548,NCT04481204,NCT04469556,NCT05472259,NCT04927780,NCT03806309,NCT04793932,NCT02795988,NCT02178709,NCT01893294,NCT03331640
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MTOR
NCT02419495,NCT00083109 |
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
MTOR
NCT00001579,NCT00003956 |
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT00003209,NCT00023660,NCT00003078
|
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
NCT04502641,NCT00508664,NCT01312350
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT03574649,NCT03169738,NCT02419495
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
HTR6,TDP1,TSHR
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
LMNA,PMP22,NOS2
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
LMNA,TDP1,SMN1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
NOS2,LMNA,TSHR
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
NOS2,HTR6,THPO
|
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT00188877,NCT02434614,NCT00379262,NCT00816816,NCT00747799,NCT03020329,NCT00697905,NCT03175939,NCT00201396,NCT03668730,NCT03604965,NCT00592501,NCT01528618,NCT03306121,NCT03503136,NCT00816855,NCT00817583,NCT00677118,NCT02016417,NCT02500940,NCT04004871,NCT05433597,NCT02012062,NCT04437329,NCT04834206,NCT01245959,NCT03574324,NCT02590133,NCT01536223
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT02413853,NCT00070122,NCT04094688,NCT00851045,NCT02508077,NCT00096278,NCT01605344,NCT00967616,NCT00942266,NCT01862003,NCT00166465,NCT03069950,NCT01277406,NCT00079274,NCT00003835,NCT04068103,NCT01270438,NCT01383343,NCT02071069,NCT03300609,NCT00707889,NCT02355379,NCT01704703,NCT00025337,NCT03050814,NCT00507091,NCT00499850,NCT00387387,NCT00003873
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT01332604,NCT05229497,NCT01653470,NCT03143153,NCT05332002,NCT01183663,NCT00941499,NCT00943137,NCT01750918,NCT02024607,NCT00983541,NCT04611724,NCT00479583,NCT00500292,NCT01046864,NCT05235542,NCT02640365,NCT05329766,NCT03368859,NCT05217069,NCT02937116,NCT01633970,NCT00710736,NCT04370418,NCT03082209
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
NCT00025142,NCT05193292,NCT00023868,NCT00020501,NCT00537823,NCT01718873,NCT00786643,NCT00612586,NCT00066846,NCT00988897,NCT00202774,NCT00026364,NCT00388700,NCT00755118,NCT02842580,NCT00003254,NCT01529164,NCT00020917,NCT00427310,NCT00212589,NCT00647530,NCT01442649,NCT01479465,NCT00070434,NCT00551213,NCT00008281,NCT00384176,NCT00323011,NCT00005979,NCT00002896,NCT00354978,NCT01374425,NCT00009737,NCT02124148,NCT01736904,NCT00427570,NCT01375816,NCT00839111,NCT05253651,NCT01077739,NCT00385021,NCT00058474,NCT00501410,NCT00378716,NCT02376452,NCT00003063,NCT00544011,NCT01383707,NCT01289821,NCT00085163,NCT00284258,NCT00003594,NCT00005050,NCT00126256,NCT00006479,NCT00069121,NCT00004885,NCT02375672,NCT01442935,NCT02384850,NCT01338558,NCT01276379,NCT00862784,NCT00002593,NCT00425152,NCT01622543,NCT00003446,NCT05239741,NCT00021281,NCT00072553,NCT00006015,NCT01765582,NCT00118261,NCT00027833,NCT00008060,NCT00940303,NCT00349336,NCT00303771,NCT00321828,NCT00268333,NCT00002793,NCT00615056,NCT00004150,NCT00280176,NCT00004252,NCT02141295,NCT04337879,NCT01271166,NCT00609622,NCT00016133,NCT00176774,NCT00209625,NCT00065117,NCT00719797,NCT00720512,NCT00556413,NCT00286000,NCT00559741,NCT00335816,NCT01150045,NCT02244632,NCT00098787,NCT00958737,NCT00002716,NCT00016978,NCT00075595,NCT00055822,NCT00973609,NCT01068132,NCT01227707,NCT01465451,NCT01478594,NCT00021398,NCT00274872,NCT00797485,NCT00080951,NCT00006115,NCT00069095,NCT00265850,NCT02246049,NCT05081687,NCT00002828,NCT00003422,NCT00006468,NCT01047293,NCT00006786,NCT00571740,NCT00296608,NCT00449137,NCT00004102,NCT01417494,NCT00719199,NCT00023751,NCT00016952,NCT00002551,NCT00423696,NCT00265811,NCT01226719,NCT00002692,NCT01679327,NCT00016198,NCT00336960,NCT01286818,NCT00262808,NCT01326000,NCT00577109,NCT00209703,NCT00268398,NCT01802645,NCT01628211,NCT00889343,NCT00884767,NCT00003287,NCT02291289,NCT00066274,NCT00813137,NCT00454116,NCT00091312,NCT00077233,NCT00003001,NCT00005586,NCT01183780,NCT03487939,NCT00003543,NCT00278889,NCT01167725,NCT01205711,NCT00001428,NCT00061815,NCT00613080,NCT00778102,NCT01193452,NCT00749450,NCT00873275,NCT02415699,NCT00004005,NCT00006037,NCT00003260,NCT00143403,NCT00291785,NCT02885753,NCT00098982,NCT00952029,NCT00831181,NCT00640081,NCT00628810,NCT00026273,NCT00497497,NCT00039208,NCT00642577,NCT00202787,NCT02826837,NCT01279681,NCT00064181,NCT00002525,NCT01652482,NCT00006103,NCT00478946,NCT00866944,NCT00467142,NCT01418222,NCT00046995,NCT02494973,NCT00469443,NCT00671372,NCT02830139,NCT01263171,NCT00110721,NCT01836653,NCT00541125,NCT00199797,NCT00069108,NCT02515734,NCT00112918,NCT01133990,NCT00002893,NCT00062426,NCT00070213,NCT05035381,NCT00541112,NCT00002523,NCT01490866,NCT00002570,NCT00182715,NCT00081289,NCT00006366,NCT00721916,NCT01515787,NCT00111761,NCT00049101
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
NCT00513383,NCT04854499,NCT00274937,NCT00002774,NCT05446467,NCT02551159,NCT04164238,NCT00999700,NCT00139269,NCT01086826,NCT03169764,NCT02047201,NCT03340896,NCT00971932,NCT02268695,NCT01154920,NCT00736944,NCT01177956,NCT01233843,NCT03855384
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
MTOR,NOS2
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
NOS2,MTOR
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN1,SMN2
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
MTOR
NCT00003331 |
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT03167164,NCT00003549
|
Neoplasms of unknown behaviour of larynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F91.0 |
NCT00117572,NCT00599131
|
Intrahepatic cholangiocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.10 |
NCT03771846,NCT04961970
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT00004206,NCT03197584
|
Neoplasms of unknown behaviour of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F90.0 |
NCT02777437,NCT03484195
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00208936,NCT00526110
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
NCT00117572,NCT00117572
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT03013218,NCT03169790
|
Inflammatory carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C62 |
NCT02879513,NCT01880385
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
NCT00352755,NCT00001569
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
NCT00000122,NCT02767219
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT03042780,NCT03736720
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT04241185,NCT02710734
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
NCT00006111,NCT00003175
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NOS2
NCT02969473 |
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
NOS2,HTR6
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
NOS2,TSHR
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
HTR6,TSHR
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
LMNA,PMP22
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
THPO,TSHR
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
NOS2,SMN1
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT01524094,NCT03837977,NCT02820857,NCT03168607,NCT01858025,NCT00001569,NCT02246127,NCT04919226,NCT00953394,NCT00022178,NCT03387592,NCT00003558,NCT03092895,NCT04325425,NCT02172976,NCT05015621,NCT03164382,NCT01489566
|
Malignant neoplasms of anus or anal canalDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C00 |
NCT00003652,NCT00025090,NCT00955240,NCT00423293,NCT01324141,NCT00324415,NCT00003596,NCT00068744,NCT02369939,NCT02402842,NCT00316888,NCT02059499,NCT01621217
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT03110510,NCT04005339,NCT04722133,NCT03524508,NCT00090025,NCT03291899,NCT04217954,NCT03778593,NCT01572324,NCT01494363,NCT05052099,NCT01127555,NCT03785873
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT00660270,NCT04897854,NCT00005870,NCT03042780,NCT02355119,NCT03699319,NCT01560949,NCT00436267,NCT02128100,NCT03387098,NCT00026130,NCT01821729,NCT01867892,NCT04371224,NCT00004003,NCT00424827,NCT05360732,NCT03484299,NCT01485744,NCT02352337,NCT00262951,NCT01827553,NCT02676349,NCT02539537,NCT05466799,NCT05047991,NCT01888978,NCT04594772,NCT03941093,NCT04807972,NCT00002955,NCT02506842,NCT01754623,NCT02672917,NCT00068575,NCT03504423,NCT00463840,NCT03443492,NCT03899636,NCT00323583,NCT01632306,NCT02241551,NCT00033735,NCT00303758,NCT00059826,NCT03329248,NCT04431258,NCT04228601,NCT05462496,NCT01523457,NCT00112658,NCT01905150,NCT00601627,NCT01992705,NCT01454180,NCT03600623,NCT03136406,NCT00786006,NCT01473303,NCT04324307,NCT04589234,NCT01494506,NCT00058201,NCT03883919,NCT02311439,NCT00251355,NCT02351219,NCT01652976,NCT02028806,NCT00089024,NCT04769414,NCT04390399,NCT03487016,NCT02021422,NCT01488552,NCT05251038,NCT03586869,NCT00049348,NCT02919787,NCT00045747,NCT01489865,NCT00112697,NCT00002689,NCT02551991,NCT00416507,NCT02581215,NCT04672005,NCT00609765,NCT00003018,NCT00960284,NCT03563144,NCT01591733,NCT01688336,NCT01836432,NCT02574663,NCT00602602,NCT00003216,NCT03693677,NCT04089150,NCT02827201,NCT00275119,NCT02717091,NCT01446458,NCT00024427,NCT04161755,NCT03861702,NCT01063192,NCT03167112,NCT04084496,NCT00003049,NCT00003029,NCT02405585,NCT00010062,NCT01661088,NCT05065801,NCT02923921,NCT00417976,NCT00005871,NCT03760614,NCT03336216,NCT03563248,NCT03991962
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
NCT04908566,NCT02625610,NCT04523818,NCT03959293,NCT00183911,NCT03281369,NCT05268510,NCT02545504,NCT01567618,NCT04510064,NCT04675983,NCT02494583
|
Actinic keratosisDisease Category: X.Extension CodesDisease ICD-11 Code: XH36H6 |
NCT02281682,NCT01525329,NCT04875026,NCT00377273,NCT02289768,NCT03037541,NCT02616601,NCT05078827,NCT02019355,NCT01354717,NCT00696488
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT03443661,NCT03259035,NCT04838496,NCT03548961,NCT04418895,NCT04423965,NCT00070122,NCT02167321,NCT01554059,NCT01302613,NCT01111604,NCT00611858,NCT04170530,NCT00832299,NCT03043729,NCT05412082,NCT00807911,NCT03299660,NCT03127007,NCT03085992,NCT03975049,NCT01269216,NCT00580073,NCT01347645,NCT05009069,NCT00235898,NCT03671252,NCT01211210,NCT05378919,NCT00422864,NCT05108428,NCT02574663,NCT00349076,NCT04009876,NCT00278694,NCT03879109,NCT00101894,NCT01270438,NCT03484221,NCT02514278,NCT04215731,NCT04808323,NCT00052559,NCT02270606,NCT01650428,NCT01060007,NCT00303628,NCT02921256,NCT02704520,NCT01871571,NCT03428529,NCT03391843,NCT02423226,NCT01740648,NCT00527111,NCT01274962,NCT02942563,NCT04621370,NCT00337389,NCT00006094,NCT01376453,NCT03152370,NCT00145769,NCT01205022,NCT01238965,NCT02465593,NCT03781323,NCT04130854,NCT01013805,NCT00003799,NCT01481545,NCT02217020,NCT03161574,NCT02688712,NCT05024097,NCT00003873,NCT01500993,NCT04495088,NCT00307736,NCT01197664,NCT05253846,NCT00321685,NCT02941562,NCT00499369,NCT03921684,NCT03000374,NCT02887313,NCT05111860,NCT04165772,NCT05022030,NCT00942266,NCT05201430,NCT01716949,NCT00865189,NCT03300544,NCT05074966,NCT00025337,NCT04380337,NCT05358704,NCT01198548,NCT02319304,NCT02280070,NCT02041481,NCT01269229,NCT02340949,NCT01941641,NCT00707889,NCT02008656
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
MTOR
NCT03888677,NCT00002870,NCT00003013,NCT00309478,NCT00038402,NCT02980965,NCT04127019,NCT00615602,NCT00002784,NCT02393833,NCT00047099,NCT00431080,NCT01031030,NCT02450058,NCT00129922,NCT00309569,NCT00124111,NCT01593020,NCT00015886,NCT00331097,NCT02995772,NCT00053911,NCT03387085,NCT00014222,NCT00773695,NCT00087178,NCT02897050,NCT02132949,NCT00055679,NCT02400567,NCT01036087,NCT00872625,NCT00963729,NCT02115204,NCT01642771,NCT00533936,NCT00433420,NCT00036868,NCT00152178,NCT00002580,NCT00002582,NCT01204437,NCT00499603,NCT00625898,NCT03554109,NCT01314833,NCT00002581,NCT00002696,NCT00003577,NCT01855828,NCT00001498,NCT00012311,NCT00002579,NCT02897700,NCT00002755,NCT00152191,NCT00950300,NCT02681003,NCT00003086,NCT00629278,NCT00003893,NCT00010075,NCT00336791,NCT03175666,NCT01985841,NCT02365805,NCT00054587,NCT00311636,NCT00017095,NCT04031703,NCT02742051,NCT00630032,NCT01358877,NCT00688740,NCT00033683,NCT02115152,NCT00193011,NCT02225652,NCT00929591,NCT00003012,NCT00301925,NCT01270373,NCT01937507,NCT00776724,NCT00820547,NCT00559845,NCT01222052,NCT00756470,NCT01985724,NCT00129389,NCT01231802,NCT00005581,NCT00525759,NCT00003680,NCT00002542,NCT01216111,NCT02846428,NCT00002498,NCT01966471 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
NOS2
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NOS2
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
MTOR
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
MTOR
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
MTOR
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
HTR6
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
MTOR
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
HTR6
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
MTOR
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
HTR6
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
MTOR
|
HydrocephalusDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D64 |
MTOR
|
LymphangioleiomyomatosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB07 |
MTOR
|
Pleural mesotheliomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26 |
MTOR
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
HTR6
|
Insulin-resistance syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A44 |
NOS2
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
MTOR
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NOS2
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MTOR
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NOS2
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
NOS2
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
NOS2
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
MTOR
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
HTR6
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
HTR6
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
MTOR
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MTOR
|
Neurodegenerative disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20-8A23 |
HTR6
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
MTOR
|
Dissociative neurological symptom disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B60 |
HTR6
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
MTOR
|
Bowel habit changeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05 |
NOS2
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NOS2
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
THPO
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
NOS2
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
THPO
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT01498783
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT02419495
|
skin carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C31.0-2E67.40 |
NCT02218164
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
NCT00370760
|
Malignant neoplasms of other or unspecified parts of biliary tractDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT05350943
|
Malignant neoplasms of fallopian tube, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74.Z |
NCT02419495
|
Basal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C32 |
NCT03541252
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00625092
|
Squamous intraepithelial neoplasia, high gradeDisease Category: X.Extension CodesDisease ICD-11 Code: XH3EA2 |
NCT02059499
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
NCT00003331
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00003331
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT02419495
|
Chalazion, unspecifiedDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A02.0Z |
NCT02025023
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
NCT02591030
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT01498783
|
Squamous cell carcinoma of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.0 |
NCT03323463
|
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT00849264
|
Low grade squamous intraepithelial lesion of cervix uteriDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA15.7 |
NCT00000758
|
Transitional cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8EH1 |
NCT03197571
|
Gastrointestinal stromal tumourDisease Category: X.Extension CodesDisease ICD-11 Code: XH9HQ1 |
NCT02574663
|
Malignant neoplasms of nasal cavityDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C20 |
NCT00117572
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NCT03167177
|
Malignant neoplasms of corpus uteriDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT00782041
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00002524
|
Signet ring cell carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4546 |
NCT00217737
|
Mucinous adenocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1S75 |
NCT00068692
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT02419495
|
Malignant neoplasms of larynx, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C23.Z |
NCT00508664
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT02590367
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT00217737
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
NOS2
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
NOS2
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
NOS2
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TSHR
|
Intrauterine growth restrictionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA20.1 |
NOS2
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOS2
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
NOS2
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
NOS2
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
NOS2
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
HTR6
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
THPO
|